← Leaderboards
Brian Wynne
Glaxosmithkline
$7,031,061
Attributed
$7,031,061
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$7,031,061 · 1
By mechanism
UC1$7,031,061 · 1
Top collaborators
No co-investigators on record.
Most similar at Glaxosmithkline
Same institution · by research overlap
- John T Lonsdale$9,325,244
- Colin K Ohrt$26,000
- Ken Duncan$1,211,279
- Jonathan R Seals$3,489,073
Others in their field
Top investigators on “Antimalarial Agents”
- Philip Jon Rosenthal · University Of California San Francisco$20,866,428
- Miriam K Laufer · University Of Maryland Baltimore$19,339,919
- Margaret A. Phillips · Ut Southwestern Medical Center$10,010,788
- Elizabeth A Winzeler · University Of California, San Diego$9,529,466
- Christopher V. Plowe · University Of Maryland Baltimore$9,257,467
- David Armand Fidock · Columbia University Health Sciences$8,328,208
Research focus
Antimalarial AgentsChemopreventionClinical ResearchClinical Trial Phase IHuman SubjectMalariaPediatric PharmacologyPlasmodium